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Abstract
Background: Acupuncture is increasingly used as an additional treatment for patients with Parkinson’s disease (PD).
Methods: In this functional magnetic resonance imaging study, brain activation in response to acupuncture in a
group of 12 patients with PD was compared with a group of 12 healthy participants. Acupuncture was conducted
on a specific acupoint, the right GB 34 (Yanglingquan), which is a frequently used acupoint for motor function
treatment in the oriental medical field.
Results: Acupuncture stimulation on this acupoint activates the prefrontal cortex, precentral gyrus, and putamen in
patients with PD; areas that are known to be impaired in patients with PD. Compared with healthy participants,
patients with PD showed significantly higher brain activity in the prefrontal cortex and precentral gyrus, especially
visible in the left hemisphere.
Conclusions: The neuroimaging results of our study suggest that in future acupuncture research; the prefrontal
cortex as well as the precentral gyrus should be treated for symptoms of Parkinson’s disease and that GB 34 seems
to be a suitable acupoint. Moreover, acupuncture evoked different brain activations in patients with Parkinson’s
disease than in healthy participants in our study, stressing the importance of conducting acupuncture studies on
both healthy participants as well as patients within the same study, in order to detect acupuncture efficacy.
Trial registration: KCT0001122 at cris.nih.go.kr (registration date: 20140530)
Keywords: Functional magnetic resonance imaging, Parkinson’s, Healthy, Patient
Background
Acupuncture is an important modality of complemen-
tary medicine [1,2] and numerous researchers have stud-
ied its effects [3-6]. In acupuncture studies, functional
magnetic resonance imaging (fMRI) is the most com-
monly applied method of functional neuroimaging, be-
cause it can indirectly measure brain activity and functional
changes of the brain without harmful radiation and invasive
procedures [5,7-11].
To measure the effects of acupuncture with fMRI,
studies have been conducted on healthy participants
[12-15], indicating that each acupoint has its own spe-
cific effect, and on patients with diseases, showing that
acupuncture is able to improve the symptoms of patients
[16-18]. However, to our knowledge, there has so far
been no fMRI study that directly measures and com-
pares brain activity in response to acupuncture stimulat-
ing manipulation in healthy participants to those of
patients with Parkinson’s disease (PD). Because acupunc-
ture is being used to treat patients with PD [19], it is im-
portant to conduct an fMRI study on both patients with
PD and healthy participants, to better understand the ef-
fects of acupuncture on patients with PD, and possibly
look for evidence of its functional mechanism. Moreover,
compared to healthy participants, abnormal brain activa-
tion was reported in the patients with PD [20], therefore
it is important to investigate whether acupuncture
stimulation on GB 34 has an effect on brain areas that
are known to show dysfunction.
PD is one of the most common neurodegenerative dis-
orders. Its characteristic features include rest tremor,
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alternative therapy is being used more often as a com-
plementary treatment to Western medicine for patients
with PD [24-27]. As many as 40% of patients with PD
use some form of complementary medicine during the
course of their illness [28], and among these, acupunc-
ture is popular [1]. Acupuncture has been reported to
have a neuroprotective effect in PD animal models
[4,29-32]. In particular, the acupoint GB 34 was reported to
lead to significant improvements in patients with PD
[1,33,34] and significant neuroprotective effects in PD ani-
mal models [6,35,36].
Based on the literature, we hypothesize that acupunc-
ture stimulation on GB 34 has an effect on brain areas
that are known to show dysfunction due to nigral dopa-
mine depletion: the prefrontal cortex [37], precentral
gyrus [38], thalamus [39], globus pallidus [40], caudate
[41], and putamen [38]. Moreover, our second hypoth-
esis is that a significant difference in brain activity in pa-
tients with PD compared with healthy participants will
be found.
Methods
Ethics statement
This study has been approved by the Clinical Research
Information Service (CRiS). The approved number is
“KCT0001122” and the topic is titled “Development of
Acupuncture Treatment for patient with Parkinson’s dis-
ease”. Participants were given written information and
verbal explanation concerning the study.
Participants
Twenty-four volunteers participated following written
informed consent according to the institutional guide-
lines of IRB and in accordance with the Declaration of
Helsinki. 12 participants were idiopathic patients with
PD (mean age = 53.5 years (range: 38–72), 6 males),
whereas the other 12 volunteers were healthy partici-
pants, matched for age (mean age = 55.9, (range: 35–
71)) and gender (6 males). Patients with atypical parkin-
sonian disorder, other neurological or major medical
conditions (e.g. head injury, stroke) or current psychi-
atric problems were excluded from the study. All healthy
volunteers and patients with PD were familiar with acu-
puncture stimulation to control for the acupuncture ex-
perience in the study. PD participants were diagnosed
with clinically definite idiopathic PD by a neurologist
from the Kyung Hee Medical Hospital. All were studied
in the “off” condition; 12 hours after all anti-parkinsonian
drugs had been withheld. Four patients with PD showed
right-onset, 5 patients showed left-onset and 3 patients
showed bilateral-onset. All had Hoehn and Yahr stage [42]
1, 2, or 2.5. The mean Unified Parkinson’s Disease Rating
Scale (UPDRS) [43] motor score was 7.8 (SD = 3.9). All
patients with PD were right-handed as verified by the Ed-
inburg Handedness Inventory [44]; their mean score was
99.6% (SD = 1.4). The average duration of disease was 2.7
years. Healthy participants were without any neurological
or psychiatric history and were all right-handed as verified
by the Edinburgh Handedness Inventory [44]; their mean
score was 100% (SD = 0, Additional file 1: Table S1).
Acupuncture
An eastern medical doctor with more than 5 years of
clinical experience conducted acupuncture on the right
GB 34 (Yanglingquan) (Additional file 2: Figure S1), ac-
cording to the WHO Standard Acupuncture Point Loca-
tions and according to the STRICTA norms [45]. This
acupoint, which is on the fibular aspect of the leg, in the
depression anterior and distal to the head of the fibula,
was chosen because it is reported that it leads to signifi-
cant neuroprotective effects in PD animal models [6,46]
and significant improvements in patients with PD [34,47].
For verum acupuncture stimulation (ACUP), the needle
(0.25 × 40 mm, Dong Bang Acupuncture Inc. Seoul,
Korea) was manually inserted into the right GB 34 to a
depth of approximately 1.0 cm. During ACUP, there were
blocks in which the needle was “stimulated”, for which the
needle was not only inserted into the skin, but also rotated
bidirectionally at 1 Hz and there were blocks in which the
needle was “not stimulated”, for which the needle was
only inserted into the skin and then left in place. For sham
acupuncture stimulation (SHAM) [48], a blunt type nee-
dle was used [47]. In contrast to ACUP, the blunt type
needle was not inserted into the skin. With the exception
of this, the same paradigm as for ACUP was used.
Experimental design and procedure
The participants received general instructions of the ex-
periment, followed by more detailed instructions for the
specific task. First, participants signed the informed con-
sent form, according to institutional guidelines of the
Human Research Committee of Kyung Hee Medical
Hospital. Then, all participants completed the Edinburgh
Handedness Inventory [44], Hoen and Yahr stage [42],
and were reminded of the specific task instructions of
the fMRI experiment. They were instructed not to move
their bodies and heads [49]. A block design was used.
The scanning experiment started with the SHAM condi-
tion with 5 minutes durations. Then, anatomical refer-
ence images were obtained for more than 15 minutes,
followed by the ACUP condition with 5 minutes dura-
tions (Additional file 3: Figure S2). Following the ACUP
and SHAM scannings, participants rated the intensity of
the sensation they felt [48]. Finally, after the fMRI ex-
periment, participants conducted the UPDRS [43], the
Korean Mini-Mental State Examination [50] and the
Beck Depression Inventory [51].
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A Philips 3.0 T MRI system (Philips, Netherlands) equipped
f o re c h op l a n e ri m a g i n g( E P I )w as used for data acquisition.
For each participant, 270 contiguous EPI functional volumes
(time repetition [TR]=2000 ms, time echo [TE]=35 ms,
flip angle=90°, slice thickness=4.5, matrix =96×128, field
of view [FOV]=230 ×182×135 mm, acquisition voxel
s ize=2 .4×2 .4×4 .5 mm) w e r e c o l l e c t e d . D u r i n g s c a n -
ning, participants remained in the supine position with
their heads immobilized by cushioned supports. They wore
ear plugs throughout the experiment to attenuate MRI gra-
dient noise. Moreover, they were instructed to rest with
their eyes closed and not to move. For spatial normalization
and localization, a high resolution T1-weighted anatomical
image was then acquired using a magnetization prepared
gradient echo sequence (time repetition [TR]=9.9 ms, time
echo [TE]=4.6 ms, flip angle=90°, slice thickness=1 mm,
matrix =236 ×240, field of view [FOV] =235 ×235 ×
196 mm, acquisition voxel size=1 ×1×1 mm).
MRI data analysis
fMRI data were analyzed using SPM5. The first five
volumes of each participant’s dataset were discarded to
allow for T1 equilibration. The functional EPI-blood
oxygenation level dependant (BOLD) images were rea-
ligned, and the subject-mean functional MR images
were co-registered with the corresponding structure
MR images. These images were spatially normalized
and transformed into a common space, as defined by
the SPM Montreal Neurological Institute (MNI) T1 tem-
plate. The functional EPI-BOLD images were spatially
smoothed with a Gaussian kernel of 8 mm FWHM
(full-width half-maximum).
The fMRI data were then statistically analyzed using the
general linear model and statistical parametric mapping of
SPM5. At the first-level, single-subject fixed effect analyses
were conducted. A model with the experiment conditions
was tested in each participant’s data separately. For second-
level analysis, the generated contrast images for the main
effects were assessed by conducting a one-sample t-test.
The comparison between healthy participants and patients
with PD was assessed by conducting a two-sample t-test.
Significant differences were accepted at a threshold of cor-
rected cluster level P<0 .0 5[5 2].
All local maxima are reported as Talairach coordinates.
In addition, the cluster size and the peak t value of areas
of significant increase are given. Relevant anatomical
landmarks and Brodmann areas were identified using
GingerALE (http://www.brainmap.org) and analyzed step
by step using Talairach Client (http://www.talairach.org).
The regions of interest (ROI) were fixed using Automated
Anatomical Labeling. The activated volume of ROI of
each region was measured using MRIcroN. The volume
comparison between ACUP and SHAM in each group
was assessed by conducting a paired-t test (SPSS Inc.,
Chicago, IL, USA).
Results
Psychophysical responses
The intensity of sensations measured by an average score
was reported on a scale from 0 (denoting no sensation) to
10 (denoting an unbearable sensation between patients with
PD and healthy participants during ACUP and SHAM).
The average stimulus intensities (mean ± SD)w e r ea p p r o x i -
mately similar during ACUP of patients with PD (2 ±2.4),
SHAM of patients with PD (1.3 ±2.0), ACUP of healthy par-
ticipants (1.4±2.1), and SHAM of healthy participants
(0.9 ±1.9); no significant statistical differences were
found.
PD related brain activation induced by ACUP and SHAM
in healthy participants and patients with PD
In healthy participants, the right putamen, left and
right thalamus, right caudate body, right lateral glo-
bus pallidus, exhibited significantly higher brain acti-
vation than other brain areas during ACUP. During
SHAM, healthy participants showed significant brain
activation in the right putamen, right precentral gyrus,
right inferior, frontal gyrus, right putamen and right
thalamus.
In patients with PD, the right superior frontal gyrus,
left middle frontal gyrus, left and right inferior frontal
gyrus, left and right precentral gyrus and left and right
putamen exhibited significantly higher brain activation
than other brain areas during ACUP. During SHAM,
the left superior frontal gyrus, left middle frontal
gyrus, left and right inferior frontal gyrus, left and
right precentral gyrus and right putamen exhibited
significantly higher brain activation than other brain
areas in patients with PD (Figure 1, Table 1 and Additional
file 4: Table S2).
Comparison of brain activation between healthy
participants and patients with PD during ACUP
Healthy participants showed significantly higher brain
activation in the right middle frontal gyrus, right hippo-
campus, left and right caudate body, left and right caud-
ate tail, left thalamus, right putamen, right insula and
right cingulate gyrus than patients with PD.
Moreover, patients with PD showed significantly higher
brain activation in the left inferior frontal gyrus, left pre-
central gyrus, left precuneus, left postcentral gyrus, left su-
perior temporal gyrus, left middle temporal gyrus, left
inferior temporal gyrus, left insula, left claustrum and left
fusiform gyrus than healthy participants (Additional file 5:
Figure S3 and Table 2).
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activated by ACUP and SHAM
Volume of the prefrontal cortex and precentral gyrus in-
duced by ACUP were significantly bigger than that by
SHAM (Figure 2).
Common areas activated on both patients with PD and
healthy participants during ACUP and SHAM
The volume of common areas which were activated by
ACUP was significantly larger than that by SHAM
(Figure 3).
Discussion
In this fMRI study, brain activation due to acupuncture
in a group of healthy participants and in a group of pa-
tients with PD was investigated. We hypothesized that
ACUP on GB 34 has an effect on brain areas that are
known to show dysfunction due to nigral dopamine de-
pletion. Moreover, our second hypothesis was that a dif-
ference in brain activity would be identified in patients
with PD when compared with healthy participants.
In line with our first hypothesis, our neuroimaging re-
sults show that ACUP on GB 34, among other areas, in-
deed activated the prefrontal cortex and the precentral
gyrus in patients with PD, but not in healthy participants
(Figure 1 and Table 1). Moreover, the putamen was acti-
vated in both groups. The prefrontal cortex [37], precen-
tral gyrus [38], and putamen [38] are all known to be
affected by PD. In a simple finger-tapping task, acupunc-
ture at GB34 showed a significant improvement of
motor function on the affected hand before and after
ACUP on GB34 (13.6%; P <0.05) [47], and led to in-
creased activation of the putamen and the primary
motor cortex in patients with PD [47]. The precentral
gyrus is a part of the primary motor cortex that contains
large neurons, which connect to the muscle [53]. The
putamen is interconnected with so many other struc-
tures, it works in conjunction with them to control
many types of motor skills such as motor learning, per-
formance [54], preparation [55] and movement sequences
[56]. Local impairments in the putamen may affect the
whole corticostriatal network [57]. In particular, brain
activation of the left putamen was only shown follow-
ing ACUP in patients with PD. It seems that acupunc-
ture, which is known to have an effect on the dopamine
system [58], affects these dysfunctional corticostriatal
networks.
Figure 1 Brain activation among healthy participants and patients with PD during acupuncture stimulation and sham stimulation
(one-sample t-test; with corrected cluster level P<0.05). The bar is the t value.
Table 1 PD related brain activation induced by ACUP and
SHAM in healthy participants and patients with PD
SHAM
Healthy
ACUP
Healthy
SHAM PD ACUP PD
LRLR L R L R
Prefrontal cortex o o o o o
Precentral gyrus o o o o o
Thalamus o o o
Globus pallidus o
Caudate o
Putamen o o o o o
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brain activation in the right superior and inferior frontal
gyrus and left middle and inferior frontal gyrus among
the prefrontal cortex (Additional file 5: Table S2). Con-
sistent with previous studies, our results also confirmed
that ACUP activated areas related to corticostriatal net-
works, which are impaired in patients with PD.
In addition, the thalamus [39] and the globus pallidus
[40] were, according to our first hypothesis, also acti-
vated after ACUP on GB 34; however, this was only the
case in healthy participants. More specifically, in healthy
participants, it was found that almost all brain activation
occurred in the basal ganglia. The right putamen, left
and right thalamus, right caudate, right insula, and right
lateral globus pallidus exhibited significantly higher brain
activation than other brain areas during ACUP (Table 1).
Consistent with previous studies, differences of brain ac-
tivity between ACUP and SHAM in healthy participants
were observed. ACUP on left GB34 in healthy participants
activated the right putamen, caudate body, claustrum,
thalamus, cerebellum, as well as the left caudate body,
thalamus, and cerebellum, all which are related to motor
Table 2 Comparisons of neural responses between patients with PD and healthy participants during acupuncture
stimulation
Healthy>Patients with PD Healthy< Patients with PD
Cerebral area Coordinates anatomical
location
Statistical values Coordinates anatomical
location
Statistical values
Brain region L/R Brodmann area xy z t value xy z t value
Frontal lobe
Middle frontal gyrus Right 6 21 5 48 3.19 - - - -
Inferior frontal gyrus Left 45/47 - - - - −32 29 −1 4.47
Precentral gyrus Left 4/6 - - - - −28 −29 57 5.36
Parietal lobe
Precuneus Left 7 - - - - −26 −59 36 5.37
Postcentral gyrus Left 2/3/40 - - - - −46 −19 43 5.36
Temporal lobe
Hippocampus Right 32 −35 0 4.63 - - - -
Superior temporal gyrus Left 22/38/41 - - - - −51 −22 3 4.69
Middle temporal gyrus Left 37 - - - - −40 −60 5 4.39
Inferior temporal gyrus Left 19 - - - - −44 −52 2 3.99
Sub-lobar
Caudate body Right 15 −29 27 5.04 - - - -
Caudate tail Right 25 −35 21 3.96 - - - -
Putamen Right 25 3 16 3.98 - - - -
Insula Right 13 30 −15 27 3.41 - - - -
Caudate body Left −16 −23 27 4.11 - - - -
Caudate tail Left −18 −30 26 3.92 - - - -
Thalamus Left 1 −19 4 3.88 - - - -
Insula Left 13 - - - - −45 −5 5 4.81
Claustrum Left - - - - −31 19 0 4.17
Limbic lobe
Cingulate gyrus Right 23/24/31/32 23 −13 39 4.33 - - - -
Occipital lobe
Precuneus Left 31 - - - - −27 −71 21 4.34
Fusiform gyrus Left 19 - - - - −21 −66 −8 3.99
Cluster size 9920 18776
The table describes the location of the peak voxel and the corresponding brain regions and Brodmann areas comprised by the cluster. Results are reported if
cluster level corrected P< 0.05. The voxel size is 2.4 × 2.4 × 4.5 mm. “Healthy participants> Patients with PD” indicates more activated neural responses of healthy
participants compared to patients with PD. “Healthy participants< Patients with PD” indicates more activated neural responses of patients with PD compared to
healthy participants (two-sample t test; with corrected cluster level P< 0.05).
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SHAM was given [60]. Through these results, we con-
firmed that our experimental methods were clear and re-
sulted in our acceptance of the results. Based on the
results of healthy participants, we could find abnormal re-
sponses to stimulations in patients with PD.
As can be seen in Figure 1, in patients with PD, re-
gions of the brain activated after ACUP were different
with those after ACUP in healthy participants. Patients with
PD have dysfunction due to nigral dopamine depletion,
which may cause abnormal activation of the basal ganglia
compared with healthy participants [61-63]. Previous studies
have shown that compared with healthy participants, in-
creased fMRI signals were found in patients with PD during
motor tasks [63], ankle movement [64] and motor responses
[61], because they are likely to participate in the same puta-
tive attempt by the dopamine-denervated brain to recruit
parallel motor circuits to overcome the functional deficit of
the striatocortical motor loops. In our results, areas activated
in SHAM, including the paracentral lobule, superior frontal
Figure 2 Volume of areas activated by ACUP and SHAM. ‘A’ is for the precentral gyrus and ‘B’ is for the prefrontal cortex (paired-t test; *P<0.05).
Figure 3 Common areas activated on both patients with PD and healthy participants during ACUP and SHAM. Left graph shows the
significant difference in common region volume activated by ACUP and SHAM. *P<0.005.
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neus, middle temporal gyrus, inferior temporal gyrus, claus-
trum, insula and middle occipital gyrus, all disappeared
following ACUP. Instead of that, the left putamen was acti-
vated following acupuncture. It is possible that these areas
became activated to compensate for nigral dopamine deple-
tion in patients with PD and that ACUP may calm these
areas down to normal activity levels, as observed in healthy
participants.
With respect to our second hypothesis, a comparison
of brain activation results (Table 2) showed that ACUP
indeed evoked different brain activation in patients with
PD than in healthy participants. Interestingly, patients
with PD showed significantly higher brain activation in
the prefrontal cortex and precentral gyrus, especially in
the left hemisphere. Because acupuncture in our study
was conducted on the right leg, brain activation can be
expected to be greater in opposite brain areas. Moreover,
note that the prefrontal cortex and precentral gyrus are
known to be affected by PD [37,38]. Our neuroimaging
results seem to indicate that the effects of acupuncture
treatment are visible in these areas in patients with PD,
but not in healthy participants.
However, it remains unclear why the effect of acu-
puncture on GB 34 is visible in the prefrontal cortex and
precentral gyrus and not in the thalamus, globus palli-
dus, and caudate, which are areas that are also known to
be affected by PD [38,39,41]. In previous studies [63,65],
it was found that the prefrontal cortex and precentral
gyrus were impaired in patients with PD when conduct-
ing motor tasks and that these areas are related to motor
function. Because GB 34 was reported to be involved in
motor function treatment [47], the treatment effect in
the prefrontal cortex and precentral gyrus that was
found in patients with PD in our study is in line with
previous findings in these motor task studies [63,65].
The prefrontal cortex is considered to induce actions in
accordance with internal goals [66] and has been shown
to be involved in composing and conducting voluntary
behavior [67], whereas the precentral gyrus is associated
with planning and execution of movement [68-70].
The volume activated by ACUP in the precentral gyrus
and prefrontal cortex was bigger than that by SHAM
(Figure 2). This is thought that even if the precentral
gyrus and prefrontal cortex were activated also by SHAM,
ACUP acted on the brain stronger than SHAM. Moreover,
the volume of common areas which were activated by
ACUP on both patients with PD and healthy participants
was significantly larger than that by SHAM (Figure 3).
This result suggests that the level of ACUP activation in
the brains of PD patients is similar to that of healthy par-
ticipants compared against SHAM.
The limitation of this study is that we should have ob-
served motor improvement instead of just referring to
existing literature. Moreover, the patients’ mean disease
duration of our participants was 2.67 years, which is a
relatively benign state of PD, so the results were slightly
differing from previous research and might only apply to
relatively patients with early PD.
Conclusions
Therefore, the neuroimaging results of our study suggest
that in future acupuncture research; the prefrontal cor-
tex as well as the precentral gyrus should be treated for
symptoms of Parkinson’s disease and that GB 34 seems
to be a suitable acupoint. Moreover, acupuncture evoked
different brain activations in patients with Parkinson’s
disease than in healthy participants in our study, stres-
sing the importance of conducting acupuncture studies
on both healthy participants as well as patients within
the same study, in order to detect acupuncture efficacy.
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